This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,841.00, is for the delivery of insulin glargine-yfgn U100 pens over a period ending on December 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Glargine-yfgn U100 Pen 3ML, a critical medical commodity, over a period ending on January 21, 2025. The contract has a firm fixed price ceiling value of $9,744.82 and is designated as a delivery order, without any set-aside requirements. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of insulin glargine-yfgn U100 pens, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $7,884.18 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.31, is for the delivery of insulin glargine-yfgn U100 pens. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide insulin glargine-yfgn U100 pens. The contract has a ceiling value of $1,872.71 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Glargine-yfgn U100 pens, with a ceiling value of $6,131.75 and a completion date of January 14, 2025. The contract is not designated as a set-aside and was awarded as a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This is a $17,179.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565372242 Insulin Glargine-yfgn U100 Pen 3ML. The contract has an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,395.72 firm fixed price contract is for the supply of Insulin Glargine-YFGN U100 Pen 3ML, a prescription insulin product. It is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563977468 - Insulin Glargine-YFGN U100 Pen 3ML to DLA Troop Support Medical. This $4,556.89 delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of insulin glargine-yfgn U100 pens, a critical medication, with a ceiling value of $2,028.27. The contract is a firm-fixed-price Indefinite Delivery Contract (IDC) that runs through September 2024. Amerisourcebergen has been awarded multiple IDCs by the DLA and other...